Jones Financial Companies
PROK icon

Jones Financial Companies’s ProKidney PROK Stock Holding History

Jones Financial Companies’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$160 Hold
100
– – ﹤0.01% 4610
2025
Q4 		$224 Sell
100
-3,230
-97% -$8.49K ﹤0.01% 4261
2025
Q3 		$8.29K Buy
3,330
+3,230
+3,230% +$8.6K ﹤0.01% 3161
2025
Q2 		$67 Hold
100
– – ﹤0.01% 3964
2025
Q1 		$91 Hold
100
– – ﹤0.01% 3631
2024
Q4 		$169 Buy
+100
New +$180 ﹤0.01% 3324

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Jones Financial Companies's PROK Position: Q1 2026 in Review

Jones Financial Companies held its ProKidney (PROK) position steady in Q1 2026 at 100 shares worth $160. The position accounts for ﹤0.01% of the portfolio, ranked #4610.

Jones Financial Companies first reported a position in PROK in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.29K in Q3 2025. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Jones Financial Companies held 100 shares of ProKidney worth $160 as of Q1 2026.
  • Jones Financial Companies left its ProKidney share count unchanged in Q1 2026.
  • ProKidney made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4610 holding.
  • Jones Financial Companies first reported a position in ProKidney in Q4 2024 and has held it in 6 quarters since.
  • Jones Financial Companies's ProKidney position peaked at $8.29K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.